Chronic Leukemia Perspective

• Venetoclax Shows Benefits Across a Range of Hematologic Cancers   From ASH 2018, Ann LaCasce and Jennifer Crombie from Dana-Farber discuss new trial data on venetoclax, a potent, selective inhibitor of BCL2.
  Medscape Oncology, December 2018
• Top News From ASH 2018: Slideshow Hot topics include practice change data on chronic lymphocytic leukemia, validation of the durability of CAR T cells, and a new standard of care in myeloma.
  Medscape News Slideshows, December 2018
• Time Out! A Close Look at Antibiotic Use in LTC Clinical cases illustrate the overuse of antibiotics to treat radiographic findings and lab reports, especially when prescribing over the phone.
  Medscape Infectious Diseases, October 2018
• EHA 2018 Read clinically focused news coverage of key developments from EHA 2018
  Medscape Oncology, June 2018
• A 71-Year-Old Man With Malaise: USMLE Question A 71-year-old man presents with fatigue and malaise over the past three months. He also reports a 10 lbs weight loss. What's causing these symptoms?
  Osmosis, May 2018
• A 70-Year-Old Man With Splenomegaly: USMLE Question A 70-year-old man presents with splenomegaly. What is most likely to be found upon staining his cells?
  Osmosis, April 2018
• Maximizing Response in Acute Leukemia: Pearls From ASH 2017   Drs Cortes and DeAngelo highlight the most intriguing clinical trials presented in the field of leukemia at ASH 2017.
  Medscape Oncology, January 2018
• With So Many Options, Best CLL Treatment May Be a Clinical Trial Combination regimens in CLL are already impressive, but new combinations currently being evaluated have strong potential to be even better.
  Medscape Oncology, January 2018
• Merkel Cell Carcinoma: Not Just Another Skin Cancer Merkel cell expert Paul Nghiem, MD, PhD, explains how this rare but deadly condition differs from other forms of skin cancer.
  Medscape Dermatology, October 2017
• Safety With CAR T-Cell Therapy   Dr Stephan Grupp tells the 'inside story' of issues raised at the recent FDA Oncology Drug Advisory Committee meeting on CAR T-cell therapy.
  CHOP Expert Commentary, August 2017
• European Hematology Association (EHA) 2017 Congress Read clinically focused news coverage of key developments from EHA 2017.
  theheart.org on Medscape, June 2017
• In the Era of Novel Therapies, New CLL Markers Required Experts are finding that the International Prognostic Index for CLL may have significant limitations when used in the context of novel therapies.
  Medscape Oncology, February 2017
• Top News From ASH 2016: Slideshow Practice-changing research in lymphoma and leukemia, plus growing excitement over two chimeric antigen receptor (CAR) T cell products, featured prominently at this year's meeting.
  Medscape News Slideshows, December 2016
• Cancer Moonshot: We Have Liftoff Initial reaction to the Moonshot ranged from cynicism to guarded optimism, but no one denies that momentum is building for this national cancer initiative -- and Big Data are the rocket boosters.
  Medscape Oncology, June 2016
• What's Hot in Hematologic Malignancies   Dr Bruce Cheson gives a sneak preview of the presentations in hematologic malignancies at ASCO 2016, with a look at new agents, refined combinations, and strategies to reduce toxicities.
  Medscape Oncology, May 2016
• Idelalisib Speed Bump: Shifting Gears in CLL   Dr Bruce Cheson discusses how the halt of six idelalisib trials because of adverse events, including deaths, affects research and patient management in CLL and follicular lymphoma.
  Medscape Oncology, March 2016
• New Hodgkin's Protocol: Brentuximab Vedotin and Nivolumab   The new treatment protocol may advance the goal of phasing out the use of nonspecific, cytotoxic chemotherapy as a treatment for this disease.
  Medscape Oncology, January 2016
• In Lymphoma, Chemo Challenged by New Classes, New Combinations   Drs Cheson and Flinn discuss lymphoma clinical trial data presented at the ASH 2015 meeting.
  Medscape Oncology, December 2015
• Toward a Chemotherapy-Free Future for CLL   Drs Bruce Cheson and Kanti Rai discuss some of the highlights in chronic lymphocytic leukemia clinical research from the 2015 American Society of Hematology meeting.
  Medscape Oncology, December 2015
• ASH 2015: For Lymphoma, CLL, the Action Is in Combinations   Dr Bruce Cheson previews data to be presented at the upcoming ASH 2015 meeting, the most exciting of which are from studies using combination drugs.
  Medscape Oncology, December 2015